← Open Payments lookup

PAUL SYLVAIN: Open Payments

NPI 1992132187 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$758 in 24 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $56 · 2025 $758

Food & beverage: $758
CompanyPaymentsAmount
Novo Nordisk Inc10$233
Merck Sharp & Dohme LLC6$150
Kowa Pharmaceuticals America, Inc.1$125
Mannkind Corporation1$109
AstraZeneca Pharmaceuticals LP3$78
Agios Pharmaceuticals, Inc.1$29
Amgen Inc.1$18
Lilly USA, LLC1$17

Products named: Rybelsus, ZORYVE, AFREZZA, FARXIGA, LAGEVRIO, VERQUVO, Ozempic, PYRUKYND.

Industry payments across NY — which companies pay providers there.